Nome |
# |
Vitamin D in human reproduction: the more, the better? An evidence-based critical appraisal, file de3e52b1-6760-762d-e053-3705fe0a30e0
|
351
|
Effects of myo-inositol on glucose variability in women with gestational diabetes, file de3e52b1-c443-762d-e053-3705fe0a30e0
|
163
|
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial, file de3e52b0-cb2a-762d-e053-3705fe0a30e0
|
30
|
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions, file de3e52b1-5c8f-762d-e053-3705fe0a30e0
|
26
|
Dietary management of skin health: The role of genistein, file de3e52b1-03bf-762d-e053-3705fe0a30e0
|
25
|
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes, file de3e52b0-b4be-762d-e053-3705fe0a30e0
|
20
|
The impact of kidney development on the life course: a consensus document for action, file de3e52b1-42a1-762d-e053-3705fe0a30e0
|
18
|
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women, file de3e52b2-6918-762d-e053-3705fe0a30e0
|
17
|
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis, file de3e52b1-5aad-762d-e053-3705fe0a30e0
|
10
|
Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials, file de3e52b1-9285-762d-e053-3705fe0a30e0
|
9
|
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial, file de3e52b3-d8d5-762d-e053-3705fe0a30e0
|
8
|
miRNA expression for early diagnosis of preeclampsia onset: hope or hype?, file de3e52b1-6573-762d-e053-3705fe0a30e0
|
7
|
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria, file de3e52b2-cbbc-762d-e053-3705fe0a30e0
|
7
|
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study, file de3e52b4-fa5c-762d-e053-3705fe0a30e0
|
6
|
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN., file de3e52ae-a461-762d-e053-3705fe0a30e0
|
5
|
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy, file de3e52b0-1419-762d-e053-3705fe0a30e0
|
5
|
Myo-inositol and melatonin in the menopausal transition, file de3e52b0-d6ee-762d-e053-3705fe0a30e0
|
5
|
Maternal peripheral blood CD34+ cells for prediction of fetal kidney malformations: results from a case-control analysis, file de3e52b3-33fb-762d-e053-3705fe0a30e0
|
5
|
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study, file de3e52ae-be56-762d-e053-3705fe0a30e0
|
3
|
null, file de3e52ae-d682-762d-e053-3705fe0a30e0
|
3
|
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia., file de3e52ae-d795-762d-e053-3705fe0a30e0
|
3
|
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study, file de3e52af-9900-762d-e053-3705fe0a30e0
|
3
|
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women., file de3e52af-a312-762d-e053-3705fe0a30e0
|
3
|
null, file de3e52b0-3b23-762d-e053-3705fe0a30e0
|
3
|
Effects of micronised dispersible ferric pyrophosphate combined with alpha-lactalbumin in pregnant women affected by iron deficiency anemia: results from a prospective, double-blind, randomized controlled trial, file de3e52b1-920b-762d-e053-3705fe0a30e0
|
3
|
Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials, file de3e52b2-dd85-762d-e053-3705fe0a30e0
|
3
|
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial, file de3e52b3-e897-762d-e053-3705fe0a30e0
|
3
|
Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS, file de3e52b4-b846-762d-e053-3705fe0a30e0
|
3
|
Cardiovascular effects of raloxifene hydrochloride, file de3e52ae-c050-762d-e053-3705fe0a30e0
|
2
|
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance, file de3e52ae-c3a4-762d-e053-3705fe0a30e0
|
2
|
First- and Second-Trimester ADAM12s in Down Syndrome Screening., file de3e52ae-c6b6-762d-e053-3705fe0a30e0
|
2
|
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study., file de3e52ae-c930-762d-e053-3705fe0a30e0
|
2
|
The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women, file de3e52ae-de8b-762d-e053-3705fe0a30e0
|
2
|
Genistein in the metabolic syndrome: results of a randomized clinical trial., file de3e52ae-ec2e-762d-e053-3705fe0a30e0
|
2
|
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial, file de3e52af-08a8-762d-e053-3705fe0a30e0
|
2
|
Italian risk factor-based screening for gestational diabetes., file de3e52af-a307-762d-e053-3705fe0a30e0
|
2
|
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes., file de3e52af-b0d4-762d-e053-3705fe0a30e0
|
2
|
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS, file de3e52af-b658-762d-e053-3705fe0a30e0
|
2
|
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin, file de3e52b1-c7d1-762d-e053-3705fe0a30e0
|
2
|
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review, file de3e52b3-0da1-762d-e053-3705fe0a30e0
|
2
|
Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology - assisted reproduction technology, file de3e52b3-bd85-762d-e053-3705fe0a30e0
|
2
|
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial, file de3e52b3-d283-762d-e053-3705fe0a30e0
|
2
|
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs, file de3e52b3-fe44-762d-e053-3705fe0a30e0
|
2
|
Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction, file de3e52ae-a59f-762d-e053-3705fe0a30e0
|
1
|
The management of vaginal agenesis: report of 104 cases., file de3e52ae-ad97-762d-e053-3705fe0a30e0
|
1
|
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia, file de3e52ae-bd37-762d-e053-3705fe0a30e0
|
1
|
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women, file de3e52ae-c0c8-762d-e053-3705fe0a30e0
|
1
|
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes, file de3e52ae-c160-762d-e053-3705fe0a30e0
|
1
|
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women, file de3e52ae-c244-762d-e053-3705fe0a30e0
|
1
|
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, file de3e52ae-c2e5-762d-e053-3705fe0a30e0
|
1
|
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study, file de3e52ae-ca44-762d-e053-3705fe0a30e0
|
1
|
Genistein aglycone: a new therapeutic approach to reduce endometrial hyperplasia, file de3e52ae-e788-762d-e053-3705fe0a30e0
|
1
|
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy, file de3e52ae-ed3e-762d-e053-3705fe0a30e0
|
1
|
Myo-inositol in Down syndrome amniotic fluid. A case-control study., file de3e52ae-ee8c-762d-e053-3705fe0a30e0
|
1
|
Myo-inositol may prevent gestational diabetes in PCOS women, file de3e52af-8cc0-762d-e053-3705fe0a30e0
|
1
|
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups, file de3e52af-a2ff-762d-e053-3705fe0a30e0
|
1
|
Visfatin correlates with hot flashes in postmenopausal women with metabolic syndrome: effects of genistein, file de3e52b0-cf10-762d-e053-3705fe0a30e0
|
1
|
Effects of a new vaginal cream containing visnadine, prenylflavonoids and bovine colostrum on Vaginal Health Index Score and Female Sexual Function Index in post-menopausal sexually active women affected by vaginal dryness: A pilot study, file de3e52b0-e5b0-762d-e053-3705fe0a30e0
|
1
|
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis, file de3e52b1-17a9-762d-e053-3705fe0a30e0
|
1
|
Maternal serum PAPP-A as an early marker of obstetric complications?, file de3e52b3-3f8b-762d-e053-3705fe0a30e0
|
1
|
Myo-inositol and melatonin in the menopausal transition, file de3e52b3-450f-762d-e053-3705fe0a30e0
|
1
|
Totale |
795 |